Zevra Therapeutics, Inc. financial data

Symbol
ZVRA on Nasdaq
Industry
Pharmaceutical Preparations
Location
1180 Celebration Boulevard, Suite 103, Celebration, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
KEMPHARM, INC (to 2/24/2023), KEMPHARM INC (to 6/30/2011)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 184 % -71.6%
Debt-to-equity 210 % +191%
Return On Equity -168 % -426%
Return On Assets -54.4 % -211%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.4M shares +47.4%
Common Stock, Shares, Outstanding 53.2M shares +47%
Entity Public Float 172M USD +12.6%
Common Stock, Value, Issued 5K USD +66.7%
Weighted Average Number of Shares Outstanding, Basic 47.8M shares +37.7%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 2.95M USD +1227%
Research and Development Expense 11M USD +22.2%
General and Administrative Expense 15.3M USD +76.3%
Costs and Expenses 102M USD +71%
Operating Income (Loss) -86.7M USD -98.2%
Nonoperating Income (Expense) -2.92M USD -112%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -89.7M USD -355%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -89.7M USD -339%
Earnings Per Share, Basic -2.11 USD/shares -252%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 54M USD +24.9%
Marketable Securities, Current 1.34M USD
Cash, Cash Equivalents, and Short-term Investments 67.7M USD
Accounts Receivable, after Allowance for Credit Loss, Current 16.1M USD +124%
Inventory, Net 9.84M USD +1367%
Assets, Current 99.4M USD -27.4%
Other Long-term Investments 0 USD -100%
Property, Plant and Equipment, Net 607K USD -5.45%
Operating Lease, Right-of-Use Asset 820K USD +17.5%
Intangible Assets, Net (Excluding Goodwill) 70.6M USD
Goodwill 4.7M USD
Other Assets, Noncurrent 512K USD +246%
Assets 192M USD +37.8%
Accounts Payable, Current 14M USD +287%
Accrued Liabilities, Current 0 USD -100%
Liabilities, Current 34.5M USD +58.8%
Operating Lease, Liability, Noncurrent 483K USD -6.58%
Other Liabilities, Noncurrent 5.52M USD +1215%
Liabilities 122M USD +70.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -115K USD +47.7%
Retained Earnings (Accumulated Deficit) -470M USD -38.3%
Stockholders' Equity Attributable to Parent 69.8M USD +13.4%
Liabilities and Equity 192M USD +37.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.2M USD -300%
Net Cash Provided by (Used in) Financing Activities 1.22M USD
Net Cash Provided by (Used in) Investing Activities 14.8M USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 54.8M shares +45%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -200K USD +99.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 140K USD +106%
Deferred Tax Assets, Valuation Allowance 134M USD +64.3%
Deferred Tax Assets, Gross 149M USD +81.4%
Operating Lease, Liability 1.02M USD +7.68%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -89.6M USD -330%
Lessee, Operating Lease, Liability, to be Paid 1.2M USD +15.8%
Property, Plant and Equipment, Gross 2.37M USD +5.95%
Operating Lease, Liability, Current 540K USD +24.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 146K USD -62.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 536K USD +10.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +26.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 172K USD +110%
Lessee, Operating Lease, Liability, to be Paid, Year Three 136K USD +339%
Deferred Tax Assets, Operating Loss Carryforwards 90.7M USD +36.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 161K USD
Operating Lease, Payments 123K USD -13.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5.35M USD
Depreciation, Depletion and Amortization 1.56M USD +1877%
Share-based Payment Arrangement, Expense 13.8M USD +241%
Interest Expense 2.05M USD +301%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%